Sino Biopharmaceutical Limited (1177) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Sino Biopharmaceutical Limited (1177) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sino Biopharmaceutical Limited (1177) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Sino Biopharmaceutical Limited (1177) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
24 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Sino Biopharmaceutical Limited (Sino) is a pharmaceutical company that develops, manufactures and markets Chinese medicines and chemical medicines. The companys products include kaishi (alprostadil) injections, yilunping (irbesartan/hydrochlorothiazide) tablets, spring (purarin) injections, kaifen (flurbiprofen axetil) injections, taibai (metformin hydrochloride) sustained release tablets, mingzheng (adefovir dipivoxil) capsules, tianqingganmei (magnesium isoglycyrrhizinate) injections, tianqingganping (diammonium glycyrrhizinate) enteric capsules, ganlixin (diammonium glycyrrhizinate) injections and capsules, and others. It provides long term investment services.

Sino Biopharmaceutical Limited (1177) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped th

  
Source:
Document ID
GDPH33000D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Sino Biopharmaceutical Limited, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Sino Biopharmaceutical Limited, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Sino Biopharmaceutical Limited, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Sino Biopharmaceutical Limited, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Sino Biopharmaceutical Limited, Medical Devices Deals, 2010 to YTD 201691
Sino Biopharmaceutical Limited, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Sino Biopharmaceutical Limited, Pharmaceuticals &Healthcare, Deal Details119
  Asset Purchase111
    Sino BioPharma Acquires 52% Stake In Shaoyang Orthopedic Hospital For US$10.2 Million111
  Licensing Agreements121
    Johnson &Johnson Innovation and Janssen Pharma Enter into Licensing Agreement with Chia Tai Tianqing Pharma121
    BioLineRx Enters Into Licensing Agreement with Jiangsu Chia-tai Tianqing Pharma For BL-8030132
  Equity Offering151
    Sino BioPharma Completes Private Placement Of US$79 Million152
    Sino BioPharma Completes Private Placement Of US$69 Million172
  Acquisition191
    Sino Biopharma To Acquire Additional 25% Stake In Jiangsu Chia Tai-Tianqing And Yancheng Suhai191
Sino Biopharmaceutical Limited - Key Competitors201
Key Employees211
Locations And Subsidiaries222
  Head Office221
  Other Locations &Subsidiaries222
Appendix241
  Methodology241
  About GlobalData241
  Contact Us241
  Disclaimer241

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Sino Biopharmaceutical Limited (1177) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Sino-Biopharmaceutical-Limited-1177-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7590>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Sino Biopharmaceutical Limited (1177) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Sino-Biopharmaceutical-Limited-1177-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7590>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research